IDEXX Laboratories EBIT Margin 2012-2026 | IDXX
Current and historical EBIT (Earnings Before Interest & Taxes) margin for IDEXX Laboratories (IDXX) over the last 10 years. The current EBIT profit margin for IDEXX Laboratories as of March 31, 2026 is .
| IDEXX Laboratories EBIT Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBIT | EBIT Margin |
| 2026-03-31 | $4.45B | $1.41B | 31.65% |
| 2025-12-31 | $4.30B | $1.36B | 31.63% |
| 2025-09-30 | $4.17B | $1.31B | 31.37% |
| 2025-06-30 | $4.04B | $1.26B | 31.11% |
| 2025-03-31 | $3.93B | $1.15B | 29.17% |
| 2024-12-31 | $3.90B | $1.13B | 28.96% |
| 2024-09-30 | $3.85B | $1.11B | 28.91% |
| 2024-06-30 | $3.79B | $1.08B | 28.61% |
| 2024-03-31 | $3.73B | $1.12B | 29.92% |
| 2023-12-31 | $3.66B | $1.10B | 29.93% |
| 2023-09-30 | $3.59B | $1.08B | 30.04% |
| 2023-06-30 | $3.52B | $1.05B | 29.82% |
| 2023-03-31 | $3.43B | $0.93B | 27.13% |
| 2022-12-31 | $3.37B | $0.90B | 26.68% |
| 2022-09-30 | $3.34B | $0.87B | 26.07% |
| 2022-06-30 | $3.31B | $0.85B | 25.75% |
| 2022-03-31 | $3.27B | $0.93B | 28.47% |
| 2021-12-31 | $3.22B | $0.93B | 28.99% |
| 2021-09-30 | $3.14B | $0.92B | 29.28% |
| 2021-06-30 | $3.05B | $0.86B | 28.36% |
| 2021-03-31 | $2.86B | $0.80B | 27.91% |
| 2020-12-31 | $2.71B | $0.69B | 25.64% |
| 2020-09-30 | $2.59B | $0.63B | 24.12% |
| 2020-06-30 | $2.47B | $0.59B | 23.97% |
| 2020-03-31 | $2.46B | $0.56B | 22.96% |
| 2019-12-31 | $2.41B | $0.55B | 22.98% |
| 2019-09-30 | $2.35B | $0.55B | 23.49% |
| 2019-06-30 | $2.29B | $0.53B | 23.10% |
| 2019-03-31 | $2.25B | $0.51B | 22.70% |
| 2018-12-31 | $2.21B | $0.49B | 22.19% |
| 2018-09-30 | $2.17B | $0.47B | 21.84% |
| 2018-06-30 | $2.12B | $0.46B | 21.59% |
| 2018-03-31 | $2.05B | $0.43B | 21.22% |
| 2017-12-31 | $1.97B | $0.41B | 20.98% |
| 2017-09-30 | $1.91B | $0.40B | 20.93% |
| 2017-06-30 | $1.86B | $0.39B | 20.78% |
| 2017-03-31 | $1.82B | $0.37B | 20.22% |
| 2016-12-31 | $1.78B | $0.35B | 19.71% |
| 2016-09-30 | $1.73B | $0.33B | 19.22% |
| 2016-06-30 | $1.69B | $0.32B | 18.75% |
| 2016-03-31 | $1.64B | $0.30B | 18.39% |
| 2015-12-31 | $1.60B | $0.30B | 18.74% |
| 2015-09-30 | $1.55B | $0.27B | 17.26% |
| 2015-06-30 | $1.53B | $0.27B | 17.50% |
| 2015-03-31 | $1.51B | $0.26B | 17.44% |
| 2014-12-31 | $1.49B | $0.26B | 17.50% |
| 2014-09-30 | $1.49B | $0.29B | 19.22% |
| 2014-06-30 | $1.44B | $0.28B | 19.35% |
| 2014-03-31 | $1.41B | $0.28B | 19.57% |
| 2013-12-31 | $1.38B | $0.27B | 19.32% |
| 2013-09-30 | $1.34B | $0.27B | 19.96% |
| 2013-06-30 | $1.32B | $0.27B | 20.15% |
| 2013-03-31 | $1.30B | $0.26B | 20.18% |
| 2012-12-31 | $1.29B | $0.26B | 20.25% |
| 2012-09-30 | $1.28B | $0.25B | 19.83% |
| 2012-06-30 | $1.27B | $0.25B | 19.49% |
| 2012-03-31 | $1.25B | $0.24B | 19.38% |
| 2011-12-31 | $1.22B | $0.24B | 19.36% |
| 2011-09-30 | $1.20B | $0.23B | 19.40% |
| 2011-06-30 | $1.17B | $0.23B | 19.40% |
| 2011-03-31 | $1.13B | $0.21B | 18.62% |
| 2010-12-31 | $1.10B | $0.20B | 18.48% |
| 2010-09-30 | $1.09B | $0.20B | 18.07% |
| 2010-06-30 | $1.08B | $0.19B | 17.70% |
| 2010-03-31 | $1.06B | $0.19B | 17.39% |
| 2009-12-31 | $1.03B | $0.18B | 16.97% |
| 2009-09-30 | $1.00B | $0.17B | 16.63% |
| 2009-06-30 | $1.00B | $0.16B | 16.27% |
| 2009-03-31 | $1.01B | $0.17B | 17.01% |
| 2008-12-31 | $1.02B | $0.17B | 16.89% |
| 2008-09-30 | $1.03B | $0.17B | 16.96% |
| 2008-06-30 | $1.00B | $0.17B | 17.03% |
| 2008-03-31 | $0.96B | $0.14B | 15.00% |
| 2007-12-31 | $0.92B | $0.14B | 14.75% |
| 2007-09-30 | $0.87B | $0.13B | 14.73% |
| 2007-06-30 | $0.83B | $0.13B | 15.24% |
| 2007-03-31 | $0.78B | $0.13B | 16.77% |
| 2006-12-31 | $0.74B | $0.13B | 17.21% |
| 2006-09-30 | $0.71B | $0.13B | 17.95% |
| 2006-06-30 | $0.68B | $0.12B | 18.13% |
| 2006-03-31 | $0.65B | $0.12B | 17.74% |
| 2005-12-31 | $0.64B | $0.12B | 18.03% |
| 2005-09-30 | $0.62B | $0.11B | 17.56% |
| 2005-06-30 | $0.59B | $0.11B | 17.94% |
| 2005-03-31 | $0.57B | $0.11B | 19.05% |
| 2004-12-31 | $0.55B | $0.11B | 19.53% |
| 2004-09-30 | $0.53B | $0.10B | 18.71% |
| 2004-06-30 | $0.52B | $0.09B | 18.25% |
| 2004-03-31 | $0.50B | $0.09B | 17.40% |
| 2003-12-31 | $0.48B | $0.08B | 16.60% |
| 2003-09-30 | $0.46B | $0.08B | 18.16% |
| 2003-06-30 | $0.44B | $0.08B | 17.65% |
| 2003-03-31 | $0.43B | $0.07B | 17.14% |
| 2002-12-31 | $0.41B | $0.07B | 15.94% |
| 2002-09-30 | $0.40B | $0.06B | 15.38% |
| 2002-06-30 | $0.40B | $0.06B | 14.90% |
| 2002-03-31 | $0.39B | $0.06B | 14.03% |
| 2001-12-31 | $0.39B | $0.06B | 14.51% |
| 2001-09-30 | $0.38B | $0.05B | 14.14% |
| 2001-06-30 | $0.38B | $0.05B | 14.13% |
| 2001-03-31 | $0.37B | $0.05B | 14.17% |
| 2000-12-31 | $0.37B | $0.05B | 14.44% |
| 2000-09-30 | $0.37B | $0.05B | 14.52% |
| 2000-06-30 | $0.36B | $0.05B | 14.17% |
| 2000-03-31 | $0.36B | $0.05B | 13.69% |
| 1999-12-31 | $0.36B | $0.05B | 13.17% |
| 1999-09-30 | $0.35B | $0.04B | 12.54% |
| 1999-06-30 | $0.34B | $0.04B | 11.66% |
| 1999-03-31 | $0.33B | $0.04B | 10.54% |
| 1998-12-31 | $0.32B | $0.03B | 9.38% |
| 1998-09-30 | $0.31B | $0.02B | 6.15% |
| 1998-06-30 | $0.30B | $0.01B | 4.29% |
| 1998-03-31 | $0.28B | $0.00B | 0.36% |
| 1997-12-31 | $0.26B | $0.00B | -1.52% |
| 1997-09-30 | $0.27B | $0.01B | 4.12% |
| 1997-06-30 | $0.27B | $0.02B | 8.30% |
| 1997-03-31 | $0.27B | $0.04B | 13.97% |
| 1996-12-31 | $0.27B | $0.05B | 17.91% |
| 1996-09-30 | $0.25B | $0.04B | 17.81% |
| 1996-06-30 | $0.23B | $0.04B | 17.70% |
| 1996-03-31 | $0.21B | $0.04B | 17.87% |
| 1995-12-31 | $0.19B | $0.03B | 17.46% |
| 1995-09-30 | $0.17B | $0.03B | 14.62% |
| 1995-06-30 | $0.15B | $0.02B | 14.29% |
| 1995-03-31 | $0.14B | $0.02B | 14.49% |
| 1994-12-31 | $0.13B | $0.02B | 14.29% |
| 1994-09-30 | $0.12B | $0.02B | 18.80% |
| 1994-06-30 | $0.11B | $0.02B | 18.35% |
| 1994-03-31 | $0.10B | $0.02B | 16.83% |
| 1993-12-31 | $0.09B | $0.02B | 16.13% |
| 1993-09-30 | $0.08B | $0.01B | 9.76% |
| 1993-06-30 | $0.07B | $0.01B | 8.22% |
| 1993-03-31 | $0.07B | $0.00B | 6.15% |
| 1992-12-31 | $0.06B | $0.00B | 5.17% |
| 1992-06-30 | $0.04B | $0.00B | 8.57% |
| 1992-03-31 | $0.03B | $0.00B | 11.11% |
| 1991-09-30 | $0.02B | $0.00B | 13.64% |
| 1991-06-30 | $0.02B | $0.00B | 14.29% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $44.716B | $4.304B |
| IDEXX Laboratories, Inc. is a developer, manufacturer and distributor of products and services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The company also sells a series of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $184.365B | 21.69 |
| Intuitive Surgical (ISRG) | United States | $160.029B | 61.73 |
| Edwards Lifesciences (EW) | United States | $44.895B | 30.42 |
| Alcon (ALC) | Switzerland | $38.585B | 25.49 |
| Waters (WAT) | United States | $31.413B | 24.37 |
| IQVIA Holdings (IQV) | United States | $28.398B | 15.40 |
| Mettler-Toledo (MTD) | United States | $26.829B | 30.97 |
| DexCom (DXCM) | United States | $24.639B | 30.63 |
| STERIS (STE) | Ireland | $21.830B | 22.08 |
| Hologic (HOLX) | United States | $16.752B | 17.53 |
| Coloplast (CLPBY) | Denmark | $15.055B | 23.03 |
| SONOVA HOLDING (SONVY) | Switzerland | $13.774B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.199B | 9.72 |
| Penumbra (PEN) | United States | $12.941B | 85.88 |
| Globus Medical (GMED) | United States | $12.230B | 22.60 |
| Masimo (MASI) | United States | $9.578B | 30.69 |
| Glaukos (GKOS) | United States | $6.760B | 0.00 |
| SARTORIUS (SSSGY) | Germany | $6.754B | 39.22 |
| Sysmex ADR (SSMXY) | Japan | $5.470B | 18.10 |
| Teleflex (TFX) | United States | $5.233B | 9.67 |
| TransMedics (TMDX) | United States | $3.910B | 40.00 |
| LivaNova (LIVN) | United Kingdom | $3.433B | 18.41 |
| Integer Holdings (ITGR) | United States | $2.900B | 13.28 |
| Veracyte (VCYT) | United States | $2.470B | 24.48 |
| Elekta AB (EKTAY) | Sweden | $2.226B | 20.13 |
| Artivion (AORT) | United States | $1.825B | 59.73 |
| AxoGen (AXGN) | United States | $1.659B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.650B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $1.642B | 18.12 |
| UFP Technologies (UFPT) | United States | $1.552B | 20.54 |
| Tandem Diabetes Care (TNDM) | United States | $1.314B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $1.308B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.269B | 0.00 |
| IRadimed (IRMD) | United States | $1.194B | 53.37 |
| OPKO Health (OPK) | United States | $0.881B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.772B | 4.44 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.659B | 15.09 |
| Alpha Tau Medical (DRTS) | Israel | $0.618B | 0.00 |
| SiBone (SIBN) | United States | $0.567B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.552B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.533B | 28.23 |
| Mesa Laboratories (MLAB) | United States | $0.530B | 13.79 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.497B | 0.00 |
| NeuroPace (NPCE) | United States | $0.480B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.405B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.405B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.404B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.393B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.346B | 143.43 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Spectral Diagnostics (EDTXF) | Canada | $0.296B | 0.00 |
| RxSight (RXST) | United States | $0.282B | 0.00 |
| 908 Devices (MASS) | United States | $0.267B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.257B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.203B | 0.00 |
| CVRx (CVRX) | United States | $0.188B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.186B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.174B | 0.00 |
| Inogen (INGN) | United States | $0.172B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.148B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.124B | 0.00 |
| Hyperfine (HYPR) | United States | $0.119B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.117B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.111B | 0.00 |
| Solana (HSDT) | United States | $0.104B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.096B | 0.00 |
| Neuronetics (STIM) | United States | $0.094B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.083B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.074B | 0.00 |
| LENSAR (LNSR) | United States | $0.069B | 0.00 |
| Positron (POSC) | United States | $0.062B | 0.00 |
| InspireMD (NSPR) | United States | $0.060B | 0.00 |
| Spectral AI (MDAI) | United States | $0.055B | 0.00 |
| DarioHealth (DRIO) | United States | $0.053B | 0.00 |
| Envoy Medical (COCH) | United States | $0.047B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.047B | 0.00 | |
| Accuray (ARAY) | United States | $0.046B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.043B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.032B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.028B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.009B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.006B | 0.00 |
| NexGel (NXGL) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| ENvue Medical (FEED) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |